Business
Featured
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
It may be too late for the FDA to change the sotorasib dosage, although in principle it could demand a new regimen before granting final approval, perhaps in 2028.
Is higher education worth the cost? New study says it depends on the school
Stanford rose to the top for providing the most bang for the buck and essentially...
The results are in: See the Best of Hartford 2024 Readers’ Poll winners
The Best Of Hartford 2024 Readers' Poll winners have been confirmed in everything from auto...
Plan for $28M UConn residence hall clears major funding hurdle; site seen as right fit
The University of Connecticut proposal for a student residence hall in downtown Hartford is on...
Anheuser-Busch’s domestic beer sales still down 1 year after Bud Light controversy
ST. LOUIS — Beer sales in North America are still down for Anheuser-Busch InBev while...
New CT pub wants guests to ‘unleash your inner Brit’ and savor fresh, authentic cuisine
"Everything I do is fresh," said the chef, who will shop locally and seasonally at...
New CT law prohibits health care providers from reporting medical debt for use in credit reports
“With Governor Lamont’s signature, Connecticut now has some of the strongest consumer protections in the...
Subscriptions are hard to cancel and easy to forget — by design
A 2022 study by brand insights agency C+R research found 42% of consumers have forgotten...